Key result
Transvenous implantation of an implantable cardioverter defibrillator via the middle cardiac vein was successfully performed without complications in a patient with a prosthetic tricuspid valve.
Why the study?
Can a transvenous ICD be successfully implanted via the middle cardiac vein in a patient with a prosthetic tricuspid valve?
Case Report (n=1)
No
Can a transvenous ICD be successfully implanted via the middle cardiac vein in a patient with a prosthetic tricuspid valve?
Transvenous ICD implantation via the middle cardiac vein is a feasible and safe alternative for secondary prevention of sudden cardiac arrest in patients with a prosthetic tricuspid valve.
May warrant consideration in select prosthetic tricuspid valve cases; hypothesis-generating and requires prospective validation before practice change.
Transvenous implantation of an implantable cardioverter defibrillator in patients with a prosthetic valve in the tricuspid position is difficult because a defibrillator lead cannot be implanted into the right ventricle through the prosthetic valve. Hence, there are three options: epicardial implantation, subcutaneous implantable cardioverter defibrillator implantation, and cardiac vein implantation. Here, we report the transvenous implantation of an implantable dual-chamber cardioverter defibrillator in a patient who had undergone tricuspid valve replacement with a prosthetic valve. The patient was a 70-year-old female with a prosthetic valve in the tricuspid position who had experienced two events of sudden cardiac arrest. We successfully performed the procedure by implanting the defibrillator lead into the middle cardiac vein. (
No takes yet. Share an insight, caveat, or question.
Lee et al. (2018) conducted a case report in Sudden cardiac arrest with prosthetic tricuspid valve (n=1). Transvenous implantation of an implantable cardioverter defibrillator (ICD) via the middle cardiac vein was evaluated on Successful implantation and absence of ventricular tachycardia. Transvenous implantation of an implantable cardioverter defibrillator via the middle cardiac vein was successfully performed without complications in a patient with a prosthetic tricuspid valve.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: